Thermage, the Hayward maker of devices to treat wrinkles, priced six million common shares in its IPO at $7 per share, to raise $42 million.

It had originally wanted to raise $86 million, but lowered its pricing plans, first to between $11 and $13, but later to between $8 and $9.

Its Nasdaq ticker is THRM.

Thermage had raised $48 million from DFJ, Essex Woodlands Health Ventures, Institutional Venture Partners, Morgenthaler and Technology Partners.